# Novartis Pharma Stein AG - Inspection Records

Source: https://www.keypedia.com/companies/novartis-pharma-stein-ag/06be1f01-8421-471e-9d38-475fef9a9c5b

> Inspection records and compliance data for Novartis Pharma Stein AG in Stein Ag. 11 FDA inspections on record, last inspected November 20, 2023.

---

## Details

- Name: Novartis Pharma Stein AG
- FEI Number: 3002653483
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK
- Address Line 1: Schaffhauserstrasse 101
- City: Stein Ag
- Country Name: Switzerland
- Address: Schaffhauserstrasse 101, Stein Ag, Switzerland
- Country: Switzerland

## Related Documents

- [483 - Novartis Pharma Stein AG - 2026-05-19](https://www.keypedia.com/records/483/novartis-pharma-stein-ag/7256aae6-5bf4-4371-ab4d-8a6f90ee21a6) — source: FDA, date: May 19, 2026
- FDA Inspection 1230809 - Novartis Pharma Stein AG - 2023-11-20 — source: FDA, date: November 20, 2023
- [483 - Novartis Pharma Stein AG - 2022-12-06](https://www.keypedia.com/records/483/novartis-pharma-stein-ag/50585e29-a34c-4320-aca5-c3193ba50374) — source: FDA, date: December 6, 2022
- [483 - Novartis Pharma Stein AG - 2022-12-06](https://www.keypedia.com/records/483/novartis-pharma-stein-ag/e63a23c8-caec-4d2b-9ed3-27a499bfdb25) — source: FDA, date: December 6, 2022
- [FDA Inspection 1192104 - Novartis Pharma Stein AG - 2022-12-06](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/5994d6f5-291c-4a32-87bf-4376f992a6bb) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 6, 2022
- [483 - Novartis Pharma Stein AG - 2018-12-04](https://www.keypedia.com/records/483/novartis-pharma-stein-ag/3e713a20-3bd1-4991-aad5-bac1eccc2725) — source: FDA, date: December 4, 2018
- [FDA Inspection 1073408 - Novartis Pharma Stein AG - 2018-12-04](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/3f2284e9-7b71-4b40-a3f0-ac4686b89e80) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 4, 2018
- [483 - Novartis Pharma Stein AG - 2018-09-21](https://www.keypedia.com/records/483/novartis-pharma-stein-ag/7b770256-872c-467d-b840-a8336bd5c659) — source: FDA, date: September 21, 2018
- [483 - Novartis Pharma Stein AG - 2017-05-09](https://www.keypedia.com/records/483/novartis-pharma-stein-ag/744bc0b9-9ae9-4b95-8ef6-c6abe8b8f1c6) — source: FDA, date: May 9, 2017
- [FDA Inspection 1015468 - Novartis Pharma Stein AG - 2017-05-09](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/41e9858b-8978-450a-9e2b-657833e31ff4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 9, 2017
- [FDA Inspection 947993 - Novartis Pharma Stein AG - 2015-10-16](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/6aecea73-0741-4c95-b1cf-6aedfc498659) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 16, 2015
- FDA Inspection 924507 - Novartis Pharma Stein AG - 2015-05-01 — classification: No Action Indicated (NAI), source: FDA, date: May 1, 2015
- FDA Inspection 875305 - Novartis Pharma Stein AG - 2014-03-25 — classification: No Action Indicated (NAI), source: FDA, date: March 25, 2014
- FDA Inspection 875305 - Novartis Pharma Stein AG - 2014-03-25 — classification: No Action Indicated (NAI), source: FDA, date: March 25, 2014
- FDA Inspection 791807 - Novartis Pharma Stein AG - 2012-06-22 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 22, 2012
- FDA Inspection 672681 - Novartis Pharma Stein AG - 2010-07-02 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 2, 2010

## Related Companies

- [Hospira Zagreb d.o.o.](https://www.keypedia.com/companies/hospira-zagreb-doo/7c1e84f8-a21e-4e90-896a-ac33304219f1)
- [Bristol-Myers Squibb Company](https://www.keypedia.com/companies/bristol-myers-squibb-company/3734a119-014f-49c6-b518-fc8b1dea7f92)
- [Amgen Manufacturing Ltd](https://www.keypedia.com/companies/amgen-manufacturing-ltd/cecb788c-4cd6-4c26-9331-7b68b4f12369)
- [Biological E. Limited](https://www.keypedia.com/companies/biological-e-limited/a02640a2-3dc0-448e-9a4f-df7e189939e4)
- [Boehringer Ingelheim Fremont, Inc.](https://www.keypedia.com/companies/boehringer-ingelheim-fremont-inc/3d7d0ca7-27cd-4223-8ade-7193417c9861)
- [Gland Pharma Limited](https://www.keypedia.com/companies/gland-pharma-limited/dd730d79-1c97-4fb0-b717-c0ebd71a5b3f)
- [Sinopep-Allsino Biopharmaceutical Co., Ltd.](https://www.keypedia.com/companies/sinopep-allsino-biopharmaceutical-co-ltd/f45b83cf-0416-4308-92bf-f7f3212ca356)
- [Merck Sharp & Dohme LLC](https://www.keypedia.com/companies/merck-sharp-dohme-llc/842c6e25-ee89-453c-a5b0-6b039c187744)
- [Eli Lilly & Company](https://www.keypedia.com/companies/eli-lilly-company/fc56eed7-d261-4de3-865e-c2aa54162adf)
- [FUJIFILM Diosynth Biotechnologies Denmark ApS](https://www.keypedia.com/companies/fujifilm-diosynth-biotechnologies-denmark-aps/513b3c42-1517-43bc-936a-d3edd26bed70)

## Related Officers

- [investigator](https://www.keypedia.com/people/don-h-bark/c91b02bc-f735-46d8-a0ef-b44724868908)
- [Ademola O. Daramola](https://www.keypedia.com/people/ademola-o-daramola/814113a4-38bc-4ce5-b6af-09c7e688c0ec)
- [Senior Regulatory Specialist](https://www.keypedia.com/people/wayne-e-seifert/e92e1f10-c61e-4b08-9156-25907e5e2942)
- [Anjali Shukla](https://www.keypedia.com/people/anjali-shukla/23e50484-91bf-436f-971e-2efd3c2b3d0a)
- [Travis S. Bradley](https://www.keypedia.com/people/travis-s-bradley/4d7756cb-65fd-4bd6-be24-25710668e6d8)
- [CSO](https://www.keypedia.com/people/mihaly-s-ligmond/2904ef70-a757-49c7-9ac4-a2c07ee36001)